Navigation Links
Stand Up to Cancer and Melanoma Research Alliance announce dream team
Date:12/14/2011

Wild-Type (BRAFwt) Cancer" Dream Team is composed of a multidisciplinary group including experts in the medical management of patients with metastatic melanoma, drug development, genomics research, biostatistics, bioinformatics and patient advocacy. It includes laboratory and clinical researchers, young investigators and senior scientists who have not worked together in the past, as well as patient advocates. In addition to Trent and LoRusso, team members include:

Principals:

  • Svetomir Markovic, M.D., Ph.D., Mayo Clinic
  • Brian Nickoloff, M.D., Ph.D., Michigan State University College of Human Medicine
  • Neal Rosen, M.D., Ph.D., Memorial Sloan-Kettering Cancer Center
  • Nicholas J. Schork, Ph.D., The Scripps Research Institute & Scripps Health
  • Aleksandar Sekulic, M.D., Ph.D., Mayo Clinic
  • Jeffrey A. Sosman, M.D., Vanderbilt University
  • Kristiina Vuori, M.D., Ph.D., Sanford-Burnham Medical Research Institute
  • Craig Webb, Ph.D., Van Andel Research Institute
  • Joshua LaBaer, M.D., Ph.D., The Biodesign Institute at Arizona State University

Advocates:

  • Mark Gorman, J.D., National Coalition for Cancer Survivorship
  • Derrick Hall, president of Arizona Diamondbacks MLB League
  • Connie Mack, U.S. Senator, Ret.
  • Jane Perlmutter, Ph.D., Gemini Group

Dream Team members come from the following institutions: Translational Genomic Research Institute, Karmanos Cancer Institute, Mayo Clinic, Michigan State University College of Human Medicine, Scripps Research Institute & Scripps Health, Van Andel Research Institute, Sanford-Burnham Medical Research Institute, Memorial Sloan-Kettering Cancer Center, Vanderbilt University, Arizona State University, Johns Hopkins University, National Cancer Institute, Queensland Institute for Medical Research, and University of California Santa Cruz.

Prior to today's announcement, SU2C has awarded grants to five Dream Teams comprised of 221 scientist
'/>"/>

Contact: Adam Pockriss
Apockriss@Rubenstein.com
212-843-8286
American Association for Cancer Research
Source:Eurekalert  

Page: 1 2 3 4 5 6

Related biology news :

1. Hidden infections crucial to understanding, controlling disease outbreaks
2. Experts agree: Environmental standards needed for biofuels
3. Field Museum provides gold standard for mammal survey
4. Proteins in sperm unlock understanding of male infertility says new study
5. Wildfires cause ozone pollution to violate health standards, new study shows
6. Experts agree: to protect the environment, biofuel standards are needed
7. IOF calls on European citizens to stand tall and speak out for their bones
8. Caltech scientists engineer supersensitive receptor, gain better understanding of dopamine system
9. NARSAD announces 2008 Prizes for Outstanding Achievement in Research on Mental Health Disorders
10. ICSU launches new program to understand the human impact on Earths life-support systems
11. Studies of small water fleas help ecologists understand population dynamics
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Stand Up to Cancer and Melanoma Research Alliance announce dream team
(Date:12/17/2014)... 15, 2014 The Defense Logistics Agency ... to detect and prevent counterfeit microcircuits from entering ... agency started performing an in-house microcircuit anti-counterfeit initiative ... authenticity of purchased microcircuits while increasing their reliability ... measures will be conducted at DLA,s Electronics Product ...
(Date:12/17/2014)... 2014  Automation is fundamentally transforming the travel ... at international borders. Over the past decade, ePassports, ... veteran travelers to self process through border control ... at an increasing number of airports, seaports, and ... According to Maxine Most , Principal at ...
(Date:12/11/2014)... , Dec. 10, 2014  That blood pressure plays a ... while. Hypertension – the medical term for high blood pressure ... 1800s, and the inflatable cuff that,s used in measuring blood ... mean there,s nothing new about hypertension, its triggers and its ... about the condition and the best ways to treat it. ...
Breaking Biology News(10 mins):Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4
... in vitro fertilization offers couples the best chance for ... cause doctors to misdiagnose a small fraction of them, ... about the accuracy of preimplantation genetic diagnosis, the method ... IVF, UF researchers set out to study the procedure. ...
... at the University of Rochester Medical Center have discovered a ... harm the function of T-cells, which regulate the body's immune ... adds insight to the latest trend in lead research, as ... to understanding the long-term burden on the body, said Michael ...
... a small vertebra at a construction site near Dallas 17 ... the fossil record. Scientists now know the significance of Turner's ... with an evolutionary twist: a land-dwelling species that became fully ... Dallas Museum of Natural History, but it took several years ...
Cached Biology News:Genetic testing still smart choice, despite uncertainties 2Genetic testing still smart choice, despite uncertainties 3The dangerous legacy of lead 2Missing fossil link 'Dallasaurus' found 2Missing fossil link 'Dallasaurus' found 3Missing fossil link 'Dallasaurus' found 4
(Date:12/24/2014)... , Dec. 23, 2014 China Biologic ... "Company"), a leading fully integrated plasma-based biopharmaceutical company ... that its majority-owned subsidiary, Shandong Taibang Biological Products ... certification from the China Food and Drug Administration ... facility. As previously disclosed in the Company,s public ...
(Date:12/24/2014)... SARASOTA, Fla. , Dec. 23, 2014  Rock ... today that it has filed a Clinical Trial Application ... Medicines Healthcare products Regulatory Agency (MHRA) seeking regulatory approval ... its lead molecule, Anatabine Citrate. Contingent on ... to conduct a Phase I trial to assess the ...
(Date:12/22/2014)... - RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSX.V: RP), ... development of autologous cell therapies, announced today the publication ... in conjunction with co-authors from Kyoto University and the ... ongoing clinical research using dermal sheath cup (DSC) cells ... The paper entitled " Hair Follicle Dermal Stem Cells ...
(Date:12/22/2014)... 22, 2014 The American ... of original research, reviews and editorials addressing developments ... practice, today published a provocative article exploring the ... progression and potential treatment of prostate cancer. ... and proposes the possibility that there could be ...
Breaking Biology Technology:China Biologic Receives GMP Certification for New Coagulation Factor Facility 2China Biologic Receives GMP Certification for New Coagulation Factor Facility 3Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 2Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 4Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 5Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 2Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 3Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 4
... ( http://www.trimarkpublications.com ), a global leader in the biotechnology, ... published Regenerative Medicine Markets report that the ... billion in 2010 and is expected to reach $4.5 ... treat injuries and diseases with specially-grown tissues by way ...
... Sept. 1 UOP LLC, a Honeywell (NYSE: ... was selected for use in Rentech, Inc.,s Rialto Renewable ... fuels. The renewable energy center, to be ... yard and tree trimmings, into renewable, ultra-clean diesel fuel ...
... PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI ... ended September 30, 2010 of approximately $86 million, as ... third quarter of 2009, a 20 percent year-over-year increase. ... 2010 sales of Avastin®, Herceptin®, Lucentis® and Tysabri® for ...
Cached Biology Technology:Regenerative Medicine Market Expected to Reach $4.5 Billion by 2014 2Honeywell UOP Technology Selected to Support Conversion of Biomass to Fuel at California Renewable Energy Facility 2Honeywell UOP Technology Selected to Support Conversion of Biomass to Fuel at California Renewable Energy Facility 3PDL BioPharma Provides Third Quarter 2010 Revenue Guidance of Approximately $86 Million and Update to its Correspondence With Genentech 2PDL BioPharma Provides Third Quarter 2010 Revenue Guidance of Approximately $86 Million and Update to its Correspondence With Genentech 3PDL BioPharma Provides Third Quarter 2010 Revenue Guidance of Approximately $86 Million and Update to its Correspondence With Genentech 4PDL BioPharma Provides Third Quarter 2010 Revenue Guidance of Approximately $86 Million and Update to its Correspondence With Genentech 5
Rat whole blood (Sprague-Dawley, averaging 7-8 weeks of age, either sex) is collected at the time of slaughter and refrigerated within 6 hours, and processed and frozen within 24 hours. The serum is ...
ELISpot kit for human Granzyme B. Kits contain PVDF plates, capture & detection antibodies, streptavidin-ALP, BSA, Skimmed dry milk, BCIP/NTB substrate, and wash buffer...
1 unit is sufficient for 1 caspase activity assay....
Anti-Rat KAPPA/LAMBDA:HRP, Clone MARK-1/MARL-15, Monoclonal Antibody...
Biology Products: